Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
Outpatient care for venous leg ulceration in Germany: A retrospective claims data analysis.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Weller Lisa, Poß-Doering Regina, Grobe Thomas, Fleischhauer Thomas, Laux Gunter, Frasch Jona, Altiner Attila, Protz Kerstin, Szecsenyi Joachim, Senft Jonas D
Аннотация
BACKGROUND AND OBJECTIVES: Outpatient care of venous leg ulcers (VLU) is a problem of high medical and health economic relevance. Treatment is often inconsistent and not guideline-compliant. The project Ulcus Cruris Care investigated the VLU outpatient care situation in Germany.
PATIENTS AND METHODS: Reimbursement data of 40,046 patient cases (2015-2019) with VLU diagnosis from a statutory health insurer (AOK Baden-Wuerttemberg, Germany) were retrospectively analyzed. Outcome assessment was based on prescriptions, medical aids, nursing care, use of compression devices, surgical procedures and treatment costs.
RESULTS: 47.3% (n = 7,581) of patients without contraindication received a compression device within 90 days. 2.3% (n = 135) received surgical truncal vein interventions. 14.1% (n = 771) received consistent compression therapy associated with faster wound healing (121.6 ± 86.2 vs. 188.1 ± 164.2 days, p < 0.001), lower total costs (4,280 ± 5,326 € vs. 5,683 ± 9,657 €, p < 0.001) and lower disease-specific costs (2,498 ± 2,785 € vs. 2,797 ± 5,145 €, p = 0.017) versus no or unsteady treatment.
CONCLUSIONS: In outpatient VLU care around 80% of patients do not receive consistent compression therapy and are therefore not adequately treated. There is an urgent need for action to improve treatment of patients with VLU in Germany.
PATIENTS AND METHODS: Reimbursement data of 40,046 patient cases (2015-2019) with VLU diagnosis from a statutory health insurer (AOK Baden-Wuerttemberg, Germany) were retrospectively analyzed. Outcome assessment was based on prescriptions, medical aids, nursing care, use of compression devices, surgical procedures and treatment costs.
RESULTS: 47.3% (n = 7,581) of patients without contraindication received a compression device within 90 days. 2.3% (n = 135) received surgical truncal vein interventions. 14.1% (n = 771) received consistent compression therapy associated with faster wound healing (121.6 ± 86.2 vs. 188.1 ± 164.2 days, p < 0.001), lower total costs (4,280 ± 5,326 € vs. 5,683 ± 9,657 €, p < 0.001) and lower disease-specific costs (2,498 ± 2,785 € vs. 2,797 ± 5,145 €, p = 0.017) versus no or unsteady treatment.
CONCLUSIONS: In outpatient VLU care around 80% of patients do not receive consistent compression therapy and are therefore not adequately treated. There is an urgent need for action to improve treatment of patients with VLU in Germany.